EcoDrugPlus

Leukotriene B4 Receptor 1

Ensembl ID : ENSONIG00000040627
Gene Symbol: LOC100689957
4 Cross references
142 Possible Orthologues:

Leukotriene B4 Receptor 1

Ensembl ID : ENSONIG00000034904
Gene Symbol: LOC100690223
3 Cross references
157 Possible Orthologues:

Leukotriene B4 Receptor 2b

Ensembl ID : ENSONIG00000041450
Gene Symbol: LTB4R2B
1 Cross references
156 Possible Orthologues:

Leukotriene B4 Receptor 2b

Ensembl ID : ENSONIG00000038412
Gene Symbol: LTB4R2B
1 Cross references
156 Possible Orthologues:

Leukotriene B4 Receptor 2b

Ensembl ID : ENSONIG00000015184
Gene Symbol: LTB4R2B
1 Cross references
157 Possible Orthologues:

Lysine (K)-Specific Demethylase 1a

Ensembl ID : ENSONIG00000004899
Gene Symbol: KDM1A
1 Cross references
212 Possible Orthologues:

Lysyl Oxidase Homolog 2a

Ensembl ID : ENSONIG00000019433
Gene Symbol: LOC100705741
4 Cross references
209 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSONIG00000016093
Gene Symbol: LOXL2
4 Cross references
213 Possible Orthologues:

Macrophage Colony-Stimulating Factor 1 Receptor 2

Ensembl ID : ENSONIG00000017788
Gene Symbol: LOC100710555
2 Cross references
204 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSONIG00000037944
Gene Symbol: MIF
3 Cross references
229 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSONIG00000020282
Gene Symbol: MST1R
3 Cross references
193 Possible Orthologues:

Macrophage-Stimulating Protein Receptor

Ensembl ID : ENSONIG00000004085
Gene Symbol: LOC100701740
2 Cross references
188 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).